TY - JOUR AU - Bray, F. PY - 2018 DA - 2018// TI - Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries JO - CA-Cancer J Clin. VL - 68 UR - https://doi.org/10.3322/caac.21492 DO - 10.3322/caac.21492 ID - Bray2018 ER - TY - JOUR AU - Veeranki, S. PY - 2011 DA - 2011// TI - IFI16 protein mediates the anti-inflammatory actions of the type-I interferons through suppression of activation of caspase-1 by inflammasomes JO - PLoS ONE VL - 6 UR - https://doi.org/10.1371/journal.pone.0027040 DO - 10.1371/journal.pone.0027040 ID - Veeranki2011 ER - TY - JOUR AU - Franchi, L. PY - 2009 DA - 2009// TI - The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis JO - Nat Immunol VL - 10 UR - https://doi.org/10.1038/ni.1703 DO - 10.1038/ni.1703 ID - Franchi2009 ER - TY - JOUR AU - Li, Z. PY - 2019 DA - 2019// TI - Low expression of AIM2 combined with high expression of pSTAT3 is associated with poor prognosis in hypopharyngeal squamous cell carcinoma JO - Oncol Rep VL - 41 ID - Li2019 ER - TY - JOUR AU - Guo, H. PY - 2015 DA - 2015// TI - Inflammasomes: mechanism of action, role in disease, and therapeutics JO - Nat Med VL - 21 UR - https://doi.org/10.1038/nm.3893 DO - 10.1038/nm.3893 ID - Guo2015 ER - TY - JOUR AU - Shi, C. S. PY - 2012 DA - 2012// TI - Activation of autophagy by inflammatory signals limits IL-1beta production by targeting ubiquitinated inflammasomes for destruction JO - Nat Immunol VL - 13 UR - https://doi.org/10.1038/ni.2215 DO - 10.1038/ni.2215 ID - Shi2012 ER - TY - JOUR AU - Saitoh, T. PY - 2008 DA - 2008// TI - Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production JO - Nature VL - 456 UR - https://doi.org/10.1038/nature07383 DO - 10.1038/nature07383 ID - Saitoh2008 ER - TY - JOUR AU - Simicek, M. PY - 2013 DA - 2013// TI - The deubiquitylase USP33 discriminates between RALB functions in autophagy and innate immune response JO - Nat Cell Biol VL - 15 UR - https://doi.org/10.1038/ncb2847 DO - 10.1038/ncb2847 ID - Simicek2013 ER - TY - JOUR AU - Yan, C. PY - 2018 DA - 2018// TI - RAL GTPases: biology and potential as therapeutic targets in cancer JO - Pharmacol Rev VL - 70 UR - https://doi.org/10.1124/pr.117.014415 DO - 10.1124/pr.117.014415 ID - Yan2018 ER - TY - JOUR AU - Zago, G. PY - 2018 DA - 2018// TI - RalB directly triggers invasion downstream Ras by mobilizing the Wave complex JO - eLife VL - 7 UR - https://doi.org/10.7554/eLife.40474 DO - 10.7554/eLife.40474 ID - Zago2018 ER - TY - JOUR AU - Yan, C. PY - 2014 DA - 2014// TI - Discovery and characterization of small molecules that target the GTPase Ral JO - Nature VL - 515 UR - https://doi.org/10.1038/nature13713 DO - 10.1038/nature13713 ID - Yan2014 ER - TY - JOUR AU - Cox, A. D. PY - 2014 DA - 2014// TI - Drugging the undruggable RAS: mission possible? JO - Nat Rev Drug Discov. VL - 13 UR - https://doi.org/10.1038/nrd4389 DO - 10.1038/nrd4389 ID - Cox2014 ER - TY - JOUR AU - Tu, Y. PY - 2011 DA - 2011// TI - The discovery of artemisinin (Qinghaosu) and gifts from Chinese medicine JO - Nat Med VL - 17 UR - https://doi.org/10.1038/nm.2471 DO - 10.1038/nm.2471 ID - Tu2011 ER - TY - JOUR AU - Duthaler, U. PY - 2012 DA - 2012// TI - Evaluation of the pharmacokinetic profile of artesunate, artemether and their metabolites in sheep naturally infected with Fasciola hepatica JO - Vet Parasitol VL - 186 UR - https://doi.org/10.1016/j.vetpar.2011.11.076 DO - 10.1016/j.vetpar.2011.11.076 ID - Duthaler2012 ER - TY - JOUR AU - Huijsduijnen, R. H. PY - 2013 DA - 2013// TI - Anticancer properties of distinct antimalarial drug classes JO - PLoS ONE VL - 8 UR - https://doi.org/10.1371/journal.pone.0082962 DO - 10.1371/journal.pone.0082962 ID - Huijsduijnen2013 ER - TY - JOUR AU - Li, P. C. PY - 2008 DA - 2008// TI - Artesunate derived from traditional Chinese medicine induces DNA damage and repair JO - Cancer Res VL - 68 UR - https://doi.org/10.1158/0008-5472.CAN-07-2970 DO - 10.1158/0008-5472.CAN-07-2970 ID - Li2008 ER - TY - JOUR AU - Disbrow, G. L. PY - 2005 DA - 2005// TI - Dihydroartemisinin is cytotoxic to papillomavirus-expressing epithelial cells in vitro and in vivo JO - Cancer Res VL - 65 UR - https://doi.org/10.1158/0008-5472.CAN-05-1216 DO - 10.1158/0008-5472.CAN-05-1216 ID - Disbrow2005 ER - TY - JOUR AU - Shi, X. PY - 2017 DA - 2017// TI - Dihydroartemisinin induces autophagy-dependent death in human tongue squamous cell carcinoma cells through DNA double-strand break-mediated oxidative stress JO - Oncotarget. VL - 8 UR - https://doi.org/10.18632/oncotarget.17520 DO - 10.18632/oncotarget.17520 ID - Shi2017 ER - TY - JOUR AU - Wang, L. PY - 2019 DA - 2019// TI - Antimalarial Dihydroartemisinin triggers autophagy within HeLa cells of human cervical cancer through Bcl-2 phosphorylation at Ser70 JO - Phytomedicine VL - 52 UR - https://doi.org/10.1016/j.phymed.2018.09.221 DO - 10.1016/j.phymed.2018.09.221 ID - Wang2019 ER - TY - JOUR AU - Shi, X. PY - 2019 DA - 2019// TI - Dihydroartemisinin, an antimalarial drug, induces absent in melanoma 2 inflammasome activation and autophagy in human hepatocellular carcinoma HepG2215 cells JO - Phytother Res. VL - 33 UR - https://doi.org/10.1002/ptr.6332 DO - 10.1002/ptr.6332 ID - Shi2019 ER - TY - JOUR AU - Lai, H. PY - 1995 DA - 1995// TI - Selective cancer cell cytotoxicity from exposure to dihydroartemisinin and holotransferrin JO - Cancer Lett VL - 91 UR - https://doi.org/10.1016/0304-3835(94)03716-V DO - 10.1016/0304-3835(94)03716-V ID - Lai1995 ER - TY - JOUR AU - Ho, W. E. PY - 2014 DA - 2014// TI - Artemisinins: pharmacological actions beyond anti-malarial JO - Pharmacol Therapeut. VL - 142 UR - https://doi.org/10.1016/j.pharmthera.2013.12.001 DO - 10.1016/j.pharmthera.2013.12.001 ID - Ho2014 ER - TY - JOUR AU - Cai, X. PY - 2011 DA - 2011// TI - Luteolin induced G2 phase cell cycle arrest and apoptosis on non-small cell lung cancer cells JO - Toxicol In Vitro VL - 25 UR - https://doi.org/10.1016/j.tiv.2011.05.009 DO - 10.1016/j.tiv.2011.05.009 ID - Cai2011 ER - TY - JOUR AU - Shi, X. i. n. l. i. PY - 2017 DA - 2017// TI - Antitumor effect of dihydroartemisinin on hypopharyngeal cancer in nude mice with transplanted tumor JO - Cancer Res Prev Treat. VL - 44 ID - Shi2017 ER - TY - JOUR AU - Wong, J. PY - 2014 DA - 2014// TI - Production of IL-1beta by bone marrow-derived macrophages in response to chemotherapeutic drugs: synergistic effects of doxorubicin and vincristine JO - Cancer Biol Ther VL - 15 UR - https://doi.org/10.4161/cbt.29922 DO - 10.4161/cbt.29922 ID - Wong2014 ER - TY - JOUR AU - Kurebayashi, Y. PY - 2018 DA - 2018// TI - Landscape of immune microenvironment in hepatocellular carcinoma and its additional impact on histological and molecular classification JO - Hepatology VL - 68 UR - https://doi.org/10.1002/hep.29904 DO - 10.1002/hep.29904 ID - Kurebayashi2018 ER - TY - JOUR AU - Chan, N. C. PY - 2014 DA - 2014// TI - Degradation of the deubiquitinating enzyme USP33 is mediated by p97 and the ubiquitin ligase HERC2 JO - J Biol Chem VL - 289 UR - https://doi.org/10.1074/jbc.M114.569392 DO - 10.1074/jbc.M114.569392 ID - Chan2014 ER - TY - JOUR AU - Mazibrada, J. PY - 2014 DA - 2014// TI - Differential expression of HER2, STAT3, SOX2, IFI16 and cell cycle markers during HPV-related head and neck carcinogenesis JO - New Microbiol VL - 37 ID - Mazibrada2014 ER - TY - JOUR AU - Kim, E. -. J. PY - 2005 DA - 2005// TI - IFI16 is an essential mediator of growth inhibition, but not differentiation, induced by the leukemia inhibitory factor/JAK/STAT pathway in medullary thyroid carcinoma cells JO - J Biol Chem VL - 280 UR - https://doi.org/10.1074/jbc.M410542200 DO - 10.1074/jbc.M410542200 ID - Kim2005 ER - TY - JOUR AU - Unterholzner, L. PY - 2010 DA - 2010// TI - IFI16 is an innate immune sensor for intracellular DNA JO - Nat Immunol VL - 11 UR - https://doi.org/10.1038/ni.1932 DO - 10.1038/ni.1932 ID - Unterholzner2010 ER - TY - JOUR AU - O’Neill, L. A. PY - 2013 DA - 2013// TI - Sensing the Dark Side of DNA JO - Science VL - 339 UR - https://doi.org/10.1126/science.1234724 DO - 10.1126/science.1234724 ID - O’Neill2013 ER - TY - JOUR AU - Goubau, D. PY - 2010 DA - 2010// TI - PYHIN proteins: center stage in DNA sensing JO - Nat Immunol VL - 11 UR - https://doi.org/10.1038/ni1110-984 DO - 10.1038/ni1110-984 ID - Goubau2010 ER - TY - JOUR AU - Gastman, B. R. PY - 2000 DA - 2000// TI - elucidation of intracellular apoptotic events JO - Blood VL - 95 UR - https://doi.org/10.1182/blood.V95.6.2015 DO - 10.1182/blood.V95.6.2015 ID - Gastman2000 ER - TY - JOUR AU - Zitvogel, L. PY - 2012 DA - 2012// TI - Inflammasomes in carcinogenesis and anticancer immune responses JO - Nat Immunol VL - 13 UR - https://doi.org/10.1038/ni.2224 DO - 10.1038/ni.2224 ID - Zitvogel2012 ER - TY - JOUR AU - Singh, V. V. PY - 2013 DA - 2013// TI - Kaposi’s sarcoma-associated herpesvirus latency in endothelial and B cells activates gamma interferon-inducible protein 16-mediated inflammasomes JO - J Virol VL - 87 UR - https://doi.org/10.1128/JVI.03282-12 DO - 10.1128/JVI.03282-12 ID - Singh2013 ER - TY - JOUR AU - St John, M. A. PY - 2015 DA - 2015// TI - Inflammatory mediators drive metastasis and drug resistance in head and neck squamous cell carcinoma JO - Laryngoscope. VL - 125 UR - https://doi.org/10.1002/lary.24998 DO - 10.1002/lary.24998 ID - St John2015 ER - TY - JOUR AU - Dunn, J. H. PY - 2012 DA - 2012// TI - Inflammasomes as molecular mediators of inflammation and cancer: potential role in melanoma JO - Cancer Lett VL - 314 UR - https://doi.org/10.1016/j.canlet.2011.10.001 DO - 10.1016/j.canlet.2011.10.001 ID - Dunn2012 ER - TY - JOUR AU - McDonald, B. PY - 2010 DA - 2010// TI - Intravascular danger signals guide neutrophils to sites of sterile inflammation JO - Science VL - 330 UR - https://doi.org/10.1126/science.1195491 DO - 10.1126/science.1195491 ID - McDonald2010 ER - TY - JOUR AU - Wu, T. PY - 2016 DA - 2016// TI - Modulation of IL-1beta reprogrammes the tumor microenvironment to interrupt oral carcinogenesis JO - Sci Rep. VL - 6 UR - https://doi.org/10.1038/srep20208 DO - 10.1038/srep20208 ID - Wu2016 ER - TY - JOUR AU - Feng, X. PY - 2017 DA - 2017// TI - The role of NLRP3 inflammasome in 5-fluorouracil resistance of oral squamous cell carcinoma JO - J Exp Clin Cancer Res. VL - 36 UR - https://doi.org/10.1186/s13046-017-0553-x DO - 10.1186/s13046-017-0553-x ID - Feng2017 ER - TY - JOUR AU - Xue, Y. PY - 2019 DA - 2019// TI - Correlation between the NLRP3 inflammasome and the prognosis of patients with LSCC JO - Front Oncol. VL - 9 UR - https://doi.org/10.3389/fonc.2019.00588 DO - 10.3389/fonc.2019.00588 ID - Xue2019 ER - TY - JOUR AU - Wang, Z. PY - 2018 DA - 2018// TI - Inflammasome and cancer JO - Exp Suppl. VL - 108 ID - Wang2018 ER - TY - JOUR AU - Bodemann, B. O. PY - 2011 DA - 2011// TI - RalB and the exocyst mediate the cellular starvation response by direct activation of autophagosome assembly JO - Cell VL - 144 UR - https://doi.org/10.1016/j.cell.2010.12.018 DO - 10.1016/j.cell.2010.12.018 ID - Bodemann2011 ER - TY - JOUR AU - Goi, T. PY - 2000 DA - 2000// TI - An EGF receptor/Ral-GTPase signaling cascade regulates c-Src activity and substrate specificity JO - EMBO J VL - 19 UR - https://doi.org/10.1093/emboj/19.4.623 DO - 10.1093/emboj/19.4.623 ID - Goi2000 ER - TY - JOUR AU - Wang, J. PY - 2007 DA - 2007// TI - Expression of STAT3 and p-STAT3 in laryngeal carcinoma and its clinical significance JO - J Clin Otorhinolaryngol Head Neck Surg. VL - 21 ID - Wang2007 ER - TY - JOUR AU - Song, Q. PY - 2015 DA - 2015// TI - Research progress of squamous cell carcinoma of head and neck EGFR targeted therapy resistance mechanisms JO - J Clin Otorhinolaryngol Head Neck Surg. VL - 29 ID - Song2015 ER - TY - JOUR AU - Jia, L. PY - 2016 DA - 2016// TI - Dihydroartemisinin as a putative STAT3 inhibitor, suppresses the growth of head and neck squamous cell carcinoma by targeting Jak2/STAT3 signaling JO - PLoS ONE VL - 11 UR - https://doi.org/10.1371/journal.pone.0147157 DO - 10.1371/journal.pone.0147157 ID - Jia2016 ER - TY - JOUR AU - Thomas, J. C. PY - 2016 DA - 2016// TI - Inhibition of Ral GTPases uusing a stapled peptide approach JO - J Biol Chem VL - 291 UR - https://doi.org/10.1074/jbc.M116.720243 DO - 10.1074/jbc.M116.720243 ID - Thomas2016 ER -